B2B healthcare marketing · Nashville, TN
Built on evidence. Designed for healthcare. Owned by your team.
Petrarch Strategy is a B2B marketing agency built entirely around the go-to-market, sales, and revenue challenges of the modern healthcare industry — every engagement, every framework.
Healthcare is the only market we work in. That focus — and the expertise it compounds — underwrites everything we build: marketing and growth systems grounded in how healthcare buys, and owned outright by the team that runs them.
Who we serve
Fluent across the full healthcare ecosystem.
Petrarch Strategy helps healthcare organizations build sustainable, long-term revenue growth — with evidence-based strategy grounded in real buyer behavior. We do that work across every corner of the industry.
Healthcare is the only market we work in.
What we do
Marketing systems, not marketing subscriptions.
We architect the foundational, evidence-based marketing and sales systems that drive cost-effective growth — built to be owned by your organization outright, with no black-box models and no dependency engineered into the engagement.
The Petrarch Diagnostic
Commercial assessmentA paid, evidence-based diagnosis of where your go-to-market is misaligned with how your market buys.
Core Strategy
Product · pricing · positioningThe single canonical answer to what you are, for whom, why, and at what price.
GTM & Tech-Stack
Measurement integrityA target-state architecture and an explicit list of what to stop measuring, and why.
Buying-Group Analysis
Marketplace researchWho sits on the committee, how each member weighs risk, what triggers the decision — and what stalls it.
Thought Leadership
Editorial authorityThe standing authority engine that makes you the company buyers remember first.
Capability Transfer
Run & transferPrograms run with your team so the capability moves inside your organization, not stays with us.
Why this matters
Not another martech layer. A durable growth strategy.
Over two decades, an entire revenue function — go-to-market, sales, and marketing alike — was rebuilt around the tools that promised to measure it. The MQL, the intent signal, the attribution model, the dashboard: each was designed for what software could capture, not for how buyers decide. Instead of growth, it produces dependence — the appearance of certainty, sold back to the teams who must answer to a board.
In healthcare, the playbook breaks down entirely. There is no intent signal for a clinical committee. No attribution model shortens an eighteen-month sales cycle. No volume of touchpoints moves a credentialed buyer who decides by consensus and reputation. The purchase is a years-long, multi-stakeholder, deeply human decision — and the company remembered first in the room is the one that gets bought, earned long before any signal fires.
Our approach
A foundation, not a funnel.
Your team needs a foundation for growth grounded in evidence, expertise, and trust. Your company needs a strategic partner who understands how the industry actually buys. Your customers need to remember you long before they enter the market.
We build that foundation around your team — establishing your company as the authority your category turns to, and compounding your growth from there.
The evidence
How your market buys.
The research on how complex B2B purchases get made is unambiguous — and most of it contradicts the playbook healthcare marketing has been sold.
Fig. II
95%
of B2B buyers are not in the market right now. Only 5% are ready to buy in a given quarter.1
Fig. III
6–10
decision-makers shape a typical complex B2B purchase — each weighing risk from a different seat.2
Fig. IV
90%
of buyers choose a vendor that was on their shortlist before the research ever began.3
Fig. V
17%
of the buying journey is spent with potential suppliers — and just 5% with any single vendor.2
1 Ehrenberg-Bass Institute · B2B Institute. 2 Gartner. 3 Bain & Company · Google.
The deal is won long before the sales conversation, by the company the committee already trusts. That is the company we build you into.
Start here
Start with the Petrarch Diagnostic.
An evidence-based diagnosis of where your go-to-market is misaligned with how your market buys — and what to fix first.